Position in ENTX
as of Dec 31, 2025
· filed Feb 17, 2026
Position Value
$125,925
-$3,054 QoQ
Shares Held
64,910
-3.4% QoQ
Ownership
0.132%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
15 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ENTX Over Time
Shares Held
Position Value (USD)
Derivatives in ENTX
reported options exposure · as of Sep 30, 2025CallValue
$40,512
CallShares
21,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,173,997,525 across 354 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
898,951 | $59,249,860 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
174,268 | $57,660,053 | |
| 3 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,344,953 | $45,499,759 | |
| 4 | ABVX |
Abivax S.A.
|
381,282 | $42,455,750 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
398,943 | $29,625,507 | |
| 6 | INSM |
INSMED Inc
|
173,630 | $28,391,977 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
593,406 | $28,228,323 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
521,571 | $27,497,223 |
All Filings in ENTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $125,925 | 64,910 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $40,512 | 21,100 | Call | Other | 2025-11-14 | |
| 2025-09-30 | $128,979 | 67,177 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $92,866 | 48,877 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $59,102 | 34,766 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $81,405 | 38,399 | Shares | Other | 2025-02-14 | |
| 2024-12-31 | $51,940 | 24,500 | Call | Other | 2025-02-14 | |
| 2024-09-30 | $39,250 | 20,658 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $53,095 | 28,856 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $86,218 | 51,628 | Shares | Defined | 2024-05-07 | |
| 2022-12-31 | $37,449 | 51,300 | Call | Defined | 2023-02-14 | |
| 2022-09-30 | $54,808 | 52,700 | Call | Defined | 2022-11-14 | |
| 2022-06-30 | $71,288 | 53,600 | Call | Defined | 2022-08-15 | |
| 2022-03-31 | $160,720 | 56,000 | Call | Defined | 2022-05-16 | |
| 2021-12-31 | $100,495 | 35,700 | Put | Defined | 2022-04-05 | |
| 2021-12-31 | $183,256 | 65,100 | Call | Defined | 2022-04-05 | |
| 2021-09-30 | $283,071 | 60,100 | Put | Defined | 2021-11-15 | |
| 2021-09-30 | $423,429 | 89,900 | Call | Defined | 2021-11-15 | |
| 2021-06-30 | $908,362 | 151,900 | Call | Defined | 2021-08-11 | |
| 2021-06-30 | $399,063 | 66,733 | Shares | Defined | 2021-08-11 | |
| 2021-06-30 | $550,758 | 92,100 | Put | Defined | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||